WAVE Life Sciences (WVE)
5.74
-0.05 (0.86%)
Upcoming Events
Latest Headlines
Wave Life Sciences schedules Singapore court hearing for US redomiciliation
July 7, 2026 4:15 PM - StreetInsider
Wave Life Sciences Announces Singapore Court Hearing, to be held on July 14, 2026 to Approve Scheme of Arrangement for Redomiciliation
July 7, 2026 4:15 PM - StreetInsider
Form 8-K Wave Life Sciences Ltd. For: Jun 22
June 26, 2026 8:30 AM - SEC Filing
Wave Life Sciences starts Phase 2a obesity trial for WVE-007 drug
June 24, 2026 8:30 AM - StreetInsider
Wave Life Sciences Announces Initiation of Phase 2a Portion of INLIGHT™ Trial of WVE-007 (INHBE GalNAc-siRNA) for Obesity and Cardiometabolic Diseases
June 24, 2026 8:30 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on WAVE Life Sciences (WVE)
June 11, 2026 6:43 AM - StreetInsider
Eco Wave Power featured in second NVIDIA keynote within three months
June 2, 2026 8:31 AM - StreetInsider
Eco Wave Power Featured for Second Time in NVIDIA Founder and CEO Jensen Huang's GTC Keynote, as Company Advances Taiwan Wave Energy Project
June 2, 2026 8:30 AM - PR NewsWire
Wave Life Sciences to Present at Upcoming Investor Conferences
June 1, 2026 8:30 AM - StreetInsider
WAVE Life Sciences (WVE) PT Raised to $14 at Wells Fargo
May 20, 2026 5:44 AM - StreetInsider
Wave Life Sciences Supports AlphaDetect to Accelerate Detection of Alpha-1
May 19, 2026 9:50 AM - PR NewsWire
WAVE Life Sciences (WVE) Reiterated at Overweight by Cantor Fitzgerald on WVE-006 Data
May 19, 2026 6:56 AM - StreetInsider
WAVE Life Sciences (WVE) PT Lowered to $13 at H.C. Wainwright
May 19, 2026 6:46 AM - StreetInsider
Form 8-K Wave Life Sciences Ltd. For: May 18
May 18, 2026 4:52 PM - SEC Filing
Wave Life Sciences reports trial progress for AATD treatment
May 18, 2026 4:30 PM - StreetInsider
Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly Dosing
May 18, 2026 4:30 PM - Globe NewsWire
Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly Dosing
May 18, 2026 4:30 PM - StreetInsider
Wave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare Conference
May 13, 2026 4:05 PM - StreetInsider
Form SCHEDULE 13G/A Wave Life Sciences Ltd. Filed by: Adage Capital Management, L.P.
May 13, 2026 9:22 AM - SEC Filing
Form DEF 14A Wave Life Sciences Ltd. For: Jun 22
May 7, 2026 4:02 PM - SEC Filing
Form SCHEDULE 13G/A Wave Life Sciences Ltd. Filed by: FMR LLC
May 6, 2026 11:41 AM - SEC Filing
Form PRER14A Wave Life Sciences Ltd.
May 1, 2026 4:22 PM - SEC Filing
WAVE Life Sciences (WVE) PT Lowered to $24 at Citi
May 1, 2026 4:23 AM - StreetInsider
Form 10-K/A Wave Life Sciences Ltd. For: Dec 31
April 30, 2026 4:20 PM - SEC Filing
WAVE Life Sciences (WVE) PT Lowered to $43 at Canaccord
April 30, 2026 6:35 AM - StreetInsider
WAVE Life Sciences (WVE) PT Lowered to $31 at B.Riley
April 29, 2026 11:32 AM - StreetInsider
Truist Securities Assumes WAVE Life Sciences (WVE) at Buy
April 29, 2026 2:51 AM - StreetInsider
RBC on WAVE Life Sciences (WVE): 'we continue to like the setup'
April 28, 2026 2:58 PM - StreetInsider
WAVE Life Sciences (WVE) PT Lowered to $19 at BofA Securities
April 28, 2026 1:13 PM - StreetInsider
WAVE Life Sciences (WVE) PT Lowered to $36 at Clear Street
April 28, 2026 12:49 PM - StreetInsider
Form 10-Q Wave Life Sciences Ltd. For: Mar 31
April 28, 2026 7:51 AM - SEC Filing
Form 8-K Wave Life Sciences Ltd. For: Apr 28
April 28, 2026 7:35 AM - SEC Filing
WAVE Life Sciences (WVE) Tops Q1 EPS by 19c
April 28, 2026 7:31 AM - StreetInsider
Wave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update
April 28, 2026 7:30 AM - Globe NewsWire
Full Article List
